During the last three months, 4 analysts shared their evaluations of Moderna (NASDAQ: MRNA ), revealing diverse outlooks from ...

Moderna Inc will soon apply for real-time reviews of its experimental COVID-19 vaccine in Europe, the drug developer said on Thursday, days after the EU health regulator launched rolling reviews of ...

Swiss contract drug manufacturer Lonza's plants in the United States and Switzerland are due to make ingredients for 400 million doses of Moderna's COVID-19 vaccine annually, Lonza said on Monday.

Venture financing for messenger ribonucleic acid (mRNA)-based innovator vaccines declined by 82% from $510m in 2023 to $90m ...

The amount of equity flowing into companies developing mRNA-based vaccines has significantly declined so far in 2025, ...

The Armenian immigrant and Flagship Pioneering visionary has spent decades turning scientific impossibilities into ...

Venture financing for mRNA-based innovator vaccines saw an 82% decline from $510 million in 2023 to $90 million in 2025 ...

A number of stocks fell in the afternoon session after worries over worsening trade relations with China were triggered by ...

How is SPY stock faring? The SPDR S&P 500 ETF Trust ($SPY) is up 1.26% over the past five days and has gained about 15.17% ...

How is VOO stock faring? The Vanguard S&P 500 ETF is up 0.73% in the past five days and 15.27% year-to-date. According to ...

Groundbreaking new tests reveal patterns in our immune systems that can signal underlying disease and tell us how well we ...

Dr Aseem Malhotra made the incendiary comments on the main stage of Reform's conference in Birmingham earlier this month.